International audienceAbstract Objectives Long-acting lipoglycopeptides are promising therapeutic options in Staphylococcus aureus bone and joint infections (BJIs). This study evaluated the ability of dalbavancin to eradicate the intraosteoblastic reservoir of S. aureus, associated with BJI chronicity. Methods Osteoblastic cells were infected with a standardized inoculum of the S. aureus reference strain HG001 and incubated for 24 h with dalbavancin, vancomycin or rifampicin using the MIC, 10×MIC, 100×MIC and/or the intraosseous concentrations reached using standard therapeutic doses (i.e. vancomycin, 10 mg/L; rifampicin, 2 mg/L; and dalbavancin, 6 mg/L). The remaining intracellular bacteria were quantified by plating cell lysates. Results ...
Antimicrobial resistance is continuously increasing among bacterial clinical isolates (especial...
The activity of dalbavancin, a representative of the lipoglycopeptide antibiotics, alone and in comb...
International audienceBackground. Diabetic foot infections (DFIs) represent a serious threat to publ...
International audienceAbstract Objectives Long-acting lipoglycopeptides are promising therapeutic op...
Dalbavancin is a new semisynthetic lipoglycopeptide with improved antimicrobial activity against var...
International audienceAlthough Staphylococcus aureus persistence in osteoblasts, partly as small-col...
Staphylococcus aureus and Staphylococcus epidermidis are leading pathogens of biofilm-related infect...
Antibiotic-loaded bone cement is the most widely used approach for the treatment of biofilm-induced ...
Dalbavancin is a lipoglycopeptide with potent activity against Gram-positive microorganisms, a long ...
Dalbavancin is a lipoglycopeptide with potent activity against Gram-positive microorganisms, a long ...
Dalbavancin (DAL) is a lipoglycopeptide with bactericidal activity against a very wide range of Gram...
The activity of dalbavancin, a representative of the lipoglycopeptide antibiotics, alone and in comb...
International audienceOBJECTIVES: Dalbavancin is a long-lasting lipoglycopeptide active against Gram...
Background: Dalbavancin is gaining interest in the treatment of complex osteoarticular (OA) infectio...
BACKGROUND: Targeting biofilm-embedded and intraosteoblastic Staphylococcus aureus, rifampicin gaine...
Antimicrobial resistance is continuously increasing among bacterial clinical isolates (especial...
The activity of dalbavancin, a representative of the lipoglycopeptide antibiotics, alone and in comb...
International audienceBackground. Diabetic foot infections (DFIs) represent a serious threat to publ...
International audienceAbstract Objectives Long-acting lipoglycopeptides are promising therapeutic op...
Dalbavancin is a new semisynthetic lipoglycopeptide with improved antimicrobial activity against var...
International audienceAlthough Staphylococcus aureus persistence in osteoblasts, partly as small-col...
Staphylococcus aureus and Staphylococcus epidermidis are leading pathogens of biofilm-related infect...
Antibiotic-loaded bone cement is the most widely used approach for the treatment of biofilm-induced ...
Dalbavancin is a lipoglycopeptide with potent activity against Gram-positive microorganisms, a long ...
Dalbavancin is a lipoglycopeptide with potent activity against Gram-positive microorganisms, a long ...
Dalbavancin (DAL) is a lipoglycopeptide with bactericidal activity against a very wide range of Gram...
The activity of dalbavancin, a representative of the lipoglycopeptide antibiotics, alone and in comb...
International audienceOBJECTIVES: Dalbavancin is a long-lasting lipoglycopeptide active against Gram...
Background: Dalbavancin is gaining interest in the treatment of complex osteoarticular (OA) infectio...
BACKGROUND: Targeting biofilm-embedded and intraosteoblastic Staphylococcus aureus, rifampicin gaine...
Antimicrobial resistance is continuously increasing among bacterial clinical isolates (especial...
The activity of dalbavancin, a representative of the lipoglycopeptide antibiotics, alone and in comb...
International audienceBackground. Diabetic foot infections (DFIs) represent a serious threat to publ...